The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Pathogenesis of liver cirrhosis
Open accessAbstract
Liver cirrhosis is the final pathological result of various chronic liver diseases, and fibrosis is the precursor of cirrhosis. Many types of cells, cytokines and miRNAs are involved in the initiation and progression of liver fibrosis and cirrhosis. Activation of hepatic stellate cells (HSCs) is a pivotal event in fibrosis. Defenestration and capillarization of liver sinusoidal endothelial cells are major contributing factors to hepatic dysfunction in liver cirrhosis. Activated Kupffer cells destroy hepatocytes and stimulate the activation of HSCs. Repeated cycles of apoptosis and regeneration of hepatocytes contribute to pathogenesis of cirrhosis. At the molecular level, many cytokines are involved in mediation of signaling pathways that regulate activation of HSCs and fibrogenesis. Recently, miRNAs as a post-transcriptional regulator have been found to play a key role in fibrosis and cirrhosis. Robust animal models of liver fibrosis and cirrhosis, as well as the recently identified critical cellular and molecular factors involved in the development of liver fibrosis and cirrhosis will facilitate the development of more effective therapeutic approaches for these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,357
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Schaff, Z., & Csmos, G. (1994) · Cited by 1,868
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Liaw, Y.-F., Leung, N., Kao, J.-H., Piratvisuth, T., Gane, E., Han, K.-H., Guan, R., Lau, G. K. K., Locarnini, S., & for the Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver (2008) · Hepatology International · doi:10.1007/s12072-008-9080-3 · Cited by 867
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
Roderburg, C., Urban, G.-W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., et al. (2011) · Hepatology · doi:10.1002/hep.23922 · Cited by 803
Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review
Braet, F., & Wisse, E. (2002) · Comparative Hepatology · doi:10.1186/1476-5926-1-1 · Cited by 753
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60777 · Cited by 735
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
The Use of Silymarin in the Treatment of Liver Diseases
Saller, R., Meier, R., & Brignoli, R. (2001) · Drugs · doi:10.2165/00003495-200161140-00003 · Cited by 718
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids
Wisse, E. (1970) · Journal of Ultrastructure Research · doi:10.1016/s0022-5320(70)90150-4 · Cited by 652
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0977com · Cited by 527
Role of Kupffer cells in the pathogenesis of liver disease
Kolios, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i46.7413 · Cited by 505
Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis
Bataller, R., & Brenner, D. A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17558 · Cited by 492
Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression
Canbay, A., Feldstein, A. E., Higuchi, H., Werneburg, N., Grambihler, A., Bronk, S. F., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50472 · Cited by 470
Anthony, P. P., Ishak, K. G., Nayak, N. C., Poulsen, H. E., Scheuer, P. J., & Sobin, L. H. (1978) · Journal of Clinical Pathology · doi:10.1136/jcp.31.5.395 · Cited by 465
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Kong, X., Feng, D., Wang, H., Hong, F., Bertola, A., Wang, F.-S., & Gao, B. (2012) · Hepatology · doi:10.1002/hep.25744 · Cited by 448
Tomita, K., Tamiya, G., Ando, S., Ohsumi, K., Chiyo, T., Mizutani, A., Kitamura, N., Toda, K., Kaneko, T., Horie, Y., et al. (2006) · Gut · doi:10.1136/gut.2005.071118 · Cited by 438
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
Elsharkawy, A. M., Oakley, F., & Mann, D. A. (2005) · Apoptosis · doi:10.1007/s10495-005-1055-4 · Cited by 419
Xie, G., Wang, X., Wang, L., Wang, L., Atkinson, R. D., Kanel, G. C., Gaarde, W. A., & DeLeve, L. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.017 · Cited by 410
DeLeve, L. D., Wang, X., & Guo, Y. (2008) · Hepatology · doi:10.1002/hep.22351 · Cited by 408
Friedman, S. L., & Arthur, M. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114362 · Cited by 401
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Ribeiro, P. S., Cortez-Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 395
Nelson, D. R., Lauwers, G. Y., Lau, J. Y. N., & Davis, G. L. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70134-x · Cited by 349
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61965-4 · Cited by 334
Underestimation of liver‐related mortality in the United States
Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., & Kim, W. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.005 · Cited by 311
Korman, J. D., Volenberg, I., Balko, J., Webster, J., Schiodt, F. V., Squires, R. H., Fontana, R. J., Lee, W. M., & Schilsky, M. L. (2008) · Hepatology · doi:10.1002/hep.22446 · Cited by 305
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., & Taub, R. (2000) · Hepatology · doi:10.1002/hep.510310123 · Cited by 298
Baroni, G. S., D’Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A. M., & Benedetti, A. (1996) · Hepatology · doi:10.1002/hep.510230538 · Cited by 295
Matsuoka, M., & Tsukamoto, H. (1990) · Hepatology · doi:10.1002/hep.1840110412 · Cited by 291
Kamari, Y., Shaish, A., Vax, E., Shemesh, S., Kandel-Kfir, M., Arbel, Y., Olteanu, S., Barshack, I., Dotan, S., Voronov, E., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.048 · Cited by 287
Cooperation of Liver Cells in Health and Disease
Kmieć, Z. (2001) · Advances in Anatomy Embryology and Cell Biology · doi:10.1007/978-3-642-56553-3 · Cited by 284
The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families
Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., & Shimotohno, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016081 · Cited by 282
Interleukin-1 participates in the progression from liver injury to fibrosis
Gieling, R. G., Wallace, K., & Han, Y.-P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90564.2008 · Cited by 281
Oakley, F., Meso, M., Iredale, J. P., Green, K., Marek, C. J., Zhou, X., May, M. J., Millward-Sadler, H., Wright, M. C., & Mann, D. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.003 · Cited by 265
In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-α
Connolly, M. K., Bedrosian, A. S., Mallen-St. Clair, J., Mitchell, A. P., Ibrahim, J., Stroud, A., Pachter, H. L., Bar-Sagi, D., Frey, A. B., & Miller, G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37581 · Cited by 263
Natural history of hepatitis C: Its impact on clinical management
Di Bisceglie, A. M. (2000) · Hepatology · doi:10.1053/he.2000.5762 · Cited by 263
Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosis
Liu, X., Hu, H., & Yin, J. Q. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01192.x · Cited by 261
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
Yang, L., Kwon, J., Popov, Y., Gajdos, G. B., Ordog, T., Brekken, R. A., Mukhopadhyay, D., Schuppan, D., Bi, Y., Simonetto, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.061 · Cited by 256
Ogawa, T., Enomoto, M., Fujii, H., Sekiya, Y., Yoshizato, K., Ikeda, K., & Kawada, N. (2012) · Gut · doi:10.1136/gutjnl-2011-300717 · Cited by 253
Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
Marvie, P., Lisbonne, M., L’Helgoualc’h, A., Rauch, M., Turlin, B., Preisser, L., Bourd‐Boittin, K., Théret, N., Gascan, H., Piquet‐Pellorce, C., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00801.x · Cited by 251
Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice
Czochra, P., Klopcic, B., Meyer, E., Herkel, J., Garcia-Lazaro, J. F., Thieringer, F., Schirmacher, P., Biesterfeld, S., Galle, P. R., Lohse, A. W., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.04.010 · Cited by 244
Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C
Arthur, M. J. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.33367 · Cited by 241
PDGF and signal transduction in hepatic stellate cells
Pinzani, M. (2002) · Frontiers in Bioscience · doi:10.2741/a875 · Cited by 239
Taimr, P., Higuchi, H., Kocova, E., Rippe, R. A., Friedman, S., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50002 · Cited by 227
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Tarantino, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i38.4773 · Cited by 225
Venugopal, S. K., Jiang, J., Kim, T.-H., Li, Y., Wang, S.-S., Torok, N. J., Wu, J., & Zern, M. A. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00220.2009 · Cited by 217
Hepatitis C and liver fibrosis
Schuppan, D., Krebs, A., Bauer, M., & Hahn, E. G. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401163 · Cited by 209
Tsai, P.-C., Fu, T.-W., Chen, Y.-M. A., Ko, T.-L., Chen, T.-H., Shih, Y.-H., Hung, S.-C., & Fu, Y.-S. (2009) · Liver Transplantation · doi:10.1002/lt.21715 · Cited by 206
Marshall, A., Rushbrook, S., Davies, S. E., Morris, L. S., Scott, I. S., Vowler, S. L., Coleman, N., & Alexander, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.076 · Cited by 205
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis
Lakner, A. M., Steuerwald, N. M., Walling, T. L., Ghosh, S., Li, T., McKillop, I. H., Russo, M. W., Bonkovsky, H. L., & Schrum, L. W. (2012) · Hepatology · doi:10.1002/hep.25613 · Cited by 204
Chuang, S.-E., Cheng, A.-L., Lin, J.-K., & Kuo, M.-L. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00101-0 · Cited by 199
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Tarantino, G., Conca, P., Pasanisi, F., Ariello, M., Mastrolia, M., Arena, A., Tarantino, M., Scopacasa, F., & Vecchione, R. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283229b40 · Cited by 185
Pro-fibrogenic potential of PDGF-D in liver fibrosis
Borkham-Kamphorst, E., van Roeyen, C. R. C., Ostendorf, T., Floege, J., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.029 · Cited by 184
Hepatic fibrosis--role of hepatic stellate cell activation.
Safadi, R., & Friedman, S. L. (2002) · PubMed · Cited by 182
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis
Trebicka, J., Anadol, E., Elfimova, N., Strack, I., Roggendorf, M., Viazov, S., Wedemeyer, I., Drebber, U., Rockstroh, J., Sauerbruch, T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.015 · Cited by 172
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis
Poupon, R., Chazouilleres, O., Corpechot, C., & Chrétien, Y. (2006) · Hepatology · doi:10.1002/hep.21229 · Cited by 170
Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats
Li, G., Xie, Q., Shi, Y., Li, D., Zhang, M., Jiang, S., Zhou, H., Lu, H., & Jin, Y. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.894 · Cited by 168
Cao, S., Yaqoob, U., Das, A., Shergill, U., Jagavelu, K., Huebert, R. C., Routray, C., Abdelmoneim, S., Vasdev, M., Leof, E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41203 · Cited by 161
Kawaguchi, K., Sakaida, I., Tsuchiya, M., Omori, K., Takami, T., & Okita, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.038 · Cited by 160
Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment
Berenguer, M., & Schuppan, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.014 · Cited by 155
Saile, B., Matthes, N., El-Armouche, H., Neubauer, K., & Ramadori, G. P. (2001) · European Journal of Cell Biology · doi:10.1078/0171-9335-00182 · Cited by 153
Borkham‐Kamphorst, E., Herrmann, J., Stoll, D., Treptau, J., Gressner, A. M., & Weiskirchen, R. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700094 · Cited by 148
Koca, S. S., Bahçecioğlu, İ. H., Poyrazoğlu, O. K., Özercan, İ. H., Şahin, K., & Üstündağ, B. (2007) · Inflammation · doi:10.1007/s10753-007-9053-z · Cited by 147
Benyon, C. R., Hovell, C. J., Gaça, M., Jones, E. H., Iredale, J. P., & Arthur, M. J. P. (1999) · Hepatology · doi:10.1002/hep.510300431 · Cited by 140
Neef, M., Ledermann, M., Saegesser, H., Schneider, V., & Reichen, J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.030 · Cited by 140
Aryl Hydrocarbon Receptor–Dependent Induction of Liver Fibrosis by Dioxin
Pierre, S., Chevallier, A., Teixeira-Clerc, F., Ambolet-Camoit, A., Bui, L. C., Bats, A., Fournet, J., Fernández‐Salguero, P. M., Aggerbeck, Μ., Lotersztajn, S., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft236 · Cited by 139
Luk, J. M., Wang, X., Liu, P., Wong, K., Chan, K., Tong, Y., Hui, C. K., Lau, G. K. K., & Fan, S. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01527.x · Cited by 136
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
Nasir, G. A., Mohsin, S., Khan, M., Shams, S., Ali, G., Khan, S. N., & Riazuddin, S. A. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-78 · Cited by 134
Roderburg, C., Luedde, M., Cardenas, D. V., Vucur, M., Mollnow, T., Zimmermann, H. W., Koch, A. H., Hellerbrand, C., Weiskirchen, R., Frey, N., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.022 · Cited by 130
Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis
Mori, T., Okanoue, T., Sawa, Y., Hori, N., Ohta, M., & Kagawa, K. (1993) · Hepatology · doi:10.1002/hep.1840170520 · Cited by 128
Chen, I.-S., Chen, Y., Chou, C., Chuang, R.-F., Sheen, L., & Chiu, C. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4723 · Cited by 128
Tan, T. C. H., Crawford, D. H., Jaskowski, L. A., Subramaniam, V. N., Clouston, A. D., Crane, D. I., Bridle, K. R., Anderson, G. J., & Fletcher, L. M. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.121 · Cited by 119
Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B
Liu, P. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i4.679 · Cited by 118
Liver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems
Ferrell, L. D. (2000) · Modern Pathology · doi:10.1038/modpathol.3880119 · Cited by 118
Foo, N., Lin, S.-H., Lee, Y., Wu, M., & Wang, Y. (2011) · Toxicology · doi:10.1016/j.tox.2011.01.009 · Cited by 116
The potential of microRNAs in liver fibrosis
He, Y., Huang, C. Z., Zhang, S., Sun, X., Long, X., & Li, J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.023 · Cited by 116
Autocrine release of TGF‐β by portal fibroblasts regulates cell growth
Wells, R. G., Kruglov, E. A., & Dranoff, J. A. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00037-7 · Cited by 114
Roderburg, C., Mollnow, T., Bongaerts, B. W. C., Elfimova, N., Cardenas, D. V., Janssen, K., Zimmermann, H. W., Koch, A. H., Vucur, M., Luedde, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032999 · Cited by 114
Osteopontin induces ductular reaction contributing to liver fibrosis
Wang, X., Lopategi, A., Ge, X., Lu, Y., Kitamura, N., Urtasun, R., Leung, T.-M., Fiel, M. I., & Nieto, N. (2014) · Gut · doi:10.1136/gutjnl-2013-306373 · Cited by 112
Hereditary hemochromatosis in the post- HFE era
Olynyk, J. K., Trinder, D., Ramm, G. A., Britton, R. S., & Bacon, B. R. (2008) · Hepatology · doi:10.1002/hep.22507 · Cited by 111
Wu, S.-J., Yang, Y., Tsuneyama, K., Leung, P. S. C., Illarionov, P. A., Gershwin, E. M., & Chuang, Y. (2010) · Hepatology · doi:10.1002/hep.24113 · Cited by 106
Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver
Straub, A., Stolz, D., Ross, M., Hernández-Zavala, A., Soucy, N. V., Klei, L., & Barchowsky, A. (2007) · Hepatology · doi:10.1002/hep.21444 · Cited by 106
Wang, B., Li, W., Guo, K., Xiao, Y., Wang, Y., & Fan, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.025 · Cited by 105
Du, W., Zhen, J., Zeng, Z.-Q., Zheng, Z., Xu, Y., Qin, L.-Y., & Chen, S. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-40 · Cited by 103
Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A2
Steib, C. J., Gerbes, A. L., Bystron, M., den Winkel, M. O., Härtl, J. M., Roggel, F., Prüfer, T., Göke, B., & Bilzer, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.019 · Cited by 100
Bhunchet, E., & Fujieda, K. (1993) · Hepatology · doi:10.1002/hep.1840180626 · Cited by 95
Borkham‐Kamphorst, E., Stoll, D., Gressner, A. M., & Weiskirchen, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.153 · Cited by 91
Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms
Gieling, R. G., Burt, A. D., & Mann, D. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.001 · Cited by 91
Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis
van Os, E., van den Broek, W. W., Mulder, P. G. H., ter Borg, P. C. J., Bruijn, J. A., & van Buuren, H. R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.036 · Cited by 87
Crespo, J., Rivero, M., Fábrega, E., Cayón, A., Amado, J., García‐Unzueta, M. T., & Pons‐Romero, F. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015835606718 · Cited by 83
Induction of microRNA-214-5p in human and rodent liver fibrosis
Iizuka, M., Ogawa, T., Enomoto, M., Motoyama, H., Yoshizato, K., Ikeda, K., & Kawada, N. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-12 · Cited by 81
Review article: the reversibility of cirrhosis
Sohrabpour, A. A., Mohamadnejad, M., & Malekzadeh, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12044 · Cited by 80
Biecker, E., Gottardi, A. D., Neef, M., Unternährer, M., Schneider, V., Ledermann, M., Sägesser, H., Shaw, S., & Reichen, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079616 · Cited by 78
Wang, J., Guo, J., Li, H., Liu, S., & Zern, M. Α. (1998) · Liver International · doi:10.1111/j.1600-0676.1998.tb00147.x · Cited by 73
Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease
Tarantino, G., Scopacasa, F., Colao, A., Capone, D., Tarantino, M., Grimaldi, E., & Savastano, S. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i48.5280 · Cited by 73
Liver cirrhosis in Malaysia: Peculiar epidemiology in a multiracial Asian country
Qua, C., & Goh, K. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06732.x · Cited by 69
Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis.
Zhang, L., Zheng, W., Chen, Y., Huang, Y., Chen, Z., Zhang, S.-J., Shi, M., & Wang, X. (2007) · PubMed · Cited by 65
Innes, H. A., Hutchinson, S. J., Barclay, S. T., Cadzow, E., Dillon, J. F., Fraser, A., Goldberg, D. J., Mills, P. R., McDonald, S., Morris, J. M., et al. (2012) · Hepatology · doi:10.1002/hep.26051 · Cited by 65
The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats
Lang, Q., Liu, Q., Xu, N., Qian, K.-L., Qi, J.-H., Sun, Y.-C., Xiao, L., & Shi, X. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.023 · Cited by 64
Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development
Ogawa, S., Ochi, T., Shimada, H., Inagaki, K., Fujita, I., Nii, A., Moffat, M. A., Katragadda, M., Violand, B. N., Arch, R. H., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00718.x · Cited by 63
Cui, Q., Wang, Z., Jiang, D., Qu, L., Guo, J., & Li, Z. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1764-4 · Cited by 63
Park, K., Hong, S. W., Hur, W., Lee, M. Y., Yang, J., Kim, S. W., Yoon, S. K., & Hahn, S. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.044 · Cited by 61
Matsuoka, M., Zhang, M. Y., & Tsukamoto, H. (1990) · Hepatology · doi:10.1002/hep.1840110204 · Cited by 61
Martin, I. V., Borkham‐Kamphorst, E., Zok, S., van Roeyen, C. R. C., Eriksson, U., Boor, P., Hittatiya, K., Fischer, H., Wasmuth, H. E., Weiskirchen, R., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.006 · Cited by 60
The effect of taurine treatment on oxidative stress in experimental liver fibrosis
Mas, M. R. (2004) · Hepatology Research · doi:10.1016/j.hepres.2003.11.012 · Cited by 59
Saile, B., Rocco, P. D., Dudás, J., El-Armouche, H., Sebb, H., Eisenbach, C., Neubauer, K., & Ramadori, G. P. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700116 · Cited by 58
An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver
Mancini, R., Benedetti, A., & Jézéquel, A. M. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00197389 · Cited by 58
Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats
Hsu, Y., Lin, Y., Chiu, Y.-T., Shiao, M., Lee, C., & Huang, Y. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-004-8167-7 · Cited by 58
Lunz, J. G., Tsuji, H., Nozaki, I., Murase, N., & Demetris, A. J. (2005) · Hepatology · doi:10.1002/hep.20709 · Cited by 57
Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A
Thieringer, F. R., Maass, T., Czochra, P., Klopcic, B. R. S., Conrad, I., Friebe, D., Schirmacher, P., Lohse, A. W., Blessing, M., Galle, P. R., et al. (2008) · Gene · doi:10.1016/j.gene.2008.05.022 · Cited by 57
Seo, K., Sohn, S.-Y., Bhang, D., Nam, M., Lee, H., & Youn, H. (2013) · Cell Biology International · doi:10.1002/cbin.10186 · Cited by 55
Chávez, E., Segovia, J., Shibayama, M., Tsutsumi, V., Vergara, P., Castro‐Sánchez, L., Salazar, E. P., Moreno, M. G., & Muriel, P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02256.x · Cited by 53
Impact of Immunosuppressive Treatment on Liver Fibrosis in Autoimmune Hepatitis
Mohamadnejad, M., Malekzadeh, R., Nasseri‐Moghaddam, S., Haghazali, S., Rakhshani, N., Tavangar, S. M., Sedaghat, M., & Alimohamadi, S. M. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2472-5 · Cited by 53
Camaschella, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmcibr1304338 · Cited by 52
Jeong, W., Do, S., Yun, H., Song, B., Kim, S., Kwak, W., Yoo, S., Park, H., & Jeong, K. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0961.x · Cited by 52
Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice
Hara, M., Kono, H., Furuya, S., Hirayama, K., Tsuchiya, M., & Fujii, H. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.03.025 · Cited by 50
Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats
Huang, Y. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i9.1386 · Cited by 49
Stå, P., Broomé, U., Scheynius, A., Befrits, R., & Hultcrantz, R. W. (1995) · Hepatology · doi:10.1002/hep.1840210514 · Cited by 49
Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver
de León, M. D. C. G., MONTFORT, I., Tello, E., López-Vancell, R., García, A. O., González-Canto, A., Néquiz, M., & Pérez-Tamayo, R. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.03.008 · Cited by 47
Gene Modulation for Treating Liver Fibrosis
Cheng, K., & Mahato, R. I. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i2.10 · Cited by 47
López-Navarrete, G., Ramos-Martínez, E., Suárez‐Álvarez, K., Aguirre‐García, J., Ledesma‐Soto, Y., León‐Cabrera, S., Gudiño‐Zayas, M., Guzmán, C., Gutiérrez‐Reyes, G., Hernández-Ruiz, J., et al. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1273 · Cited by 47
3,3′‐Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR ‐21 expression
Zhang, Z., Gao, Z., Hu, W., Yin, S., Wang, C., Zang, Y., Chen, J., Zhang, J., & Dong, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12323 · Cited by 46
Kim, S. U., Park, J. Y., Kim, D. Y., Ahn, S. H., Choi, E. H., Seok, J. Y., Lee, J. M., Park, Y. N., Chon, C. Y., & Han, K. (2010) · Hepatology International · doi:10.1007/s12072-010-9201-7 · Cited by 45
Pterostilbene inhibits dimethylnitrosamine-induced liver fibrosis in rats
Lee, M.-F., Liu, M.-L., Cheng, A., Tsai, M.-L., Ho, C., Liou, W., & Pan, M. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.11.094 · Cited by 45
Chinese medicines as a resource for liver fibrosis treatment
Feng, Y., Cheung, K.-F., Wang, N., Liu, P., Nagamatsu, T., & Tong, Y. (2009) · Chinese Medicine · doi:10.1186/1749-8546-4-16 · Cited by 44
Cui, X., Shimizu, I., Lu, G., Itonaga, M., Inoue, H., Shono, M., Tamaki, K., Fukuno, H., Ueno, H., & Ito, S. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00216-2 · Cited by 44
Du, S., Li, H., Cui, Y., Yang, L., Wu, J., Huang, H., Chen, Y., Huang, W., Zhang, R., Yang, J. X., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.03.011 · Cited by 43
Wen-ying, C. H. O. U., Lu, C.-N., Lee, T.-H., Chia-ling, W. U., Kung-sheng, H. U. N. G., Concejero, A. M., Jawan, B., & Wang, C.-H. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00304.x · Cited by 40
Jia, X., Naito, H., Yetti, H., Tamada, H., Kitamori, K., Hayashi, Y., Wang, D., Yanagiba, Y., Wang, J., Ikeda, K., et al. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2747-1 · Cited by 40
Patricio Ibáñez, L., Solís, N., Pizarro, M., Aguayo, G., Duarte, I., Miquel, J. F., Luigi Accatino, L., & Arrese, M. A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04700.x · Cited by 40
Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis
Liang, J., Zhang, B., Shen, R., Liu, J., Gao, M., Li, Y., Li, Y., & Zhang, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082232 · Cited by 39
Targeted delivery of drugs for liver fibrosis
Li, F., & Wang, J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902936834 · Cited by 38
Terai, S., Takami, T., Yamamoto, N., Fujisawa, K., Ishikawa, T., Urata, Y., Tanimoto, H., Iwamoto, T., Mizunaga, Y., Matsuda, T., et al. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0527 · Cited by 37
Øie, C. I., Appa, R. S., Hilden, I., Petersen, H. H., Gruhler, A., Smedsrød, B. H., & Hansen, J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.013 · Cited by 37
Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis
Taşçı, İ. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i23.3237 · Cited by 36
Urbanik, T., Boger, R. J., Longerich, T., Becker, K., Ehrenberg, K. R., Hövelmeyer, N., Hahn, M., Schuchmann, M., Jäger, D., Waisman, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.017 · Cited by 36
A New Strategy for Treatment of Liver Fibrosis: Letting MicroRNAs Do the Job
Chen, S., Zheng, M., Shi, K., Yang, T., & Chen, Y. (2012) · BioDrugs · doi:10.1007/s40259-012-0005-2 · Cited by 35
Pan, X., Zhao, L., Li, L., Li, A., Jin, Y., Yang, L., Xu, K., & Hou, X. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1095-x · Cited by 34
Tao, Y., Wang, Q., Shen, L., Fu, W., & Liu, C. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213498979 · Cited by 34
Schattenberg, J. M., Nagel, M. C., Kim, Y. O., Kohl, T., Wörns, M., Zimmermann, T., Schad, A., Longerich, T., Schuppan, D., He, Y.-W., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00525.2011 · Cited by 34
Başar, Ö., Yımaz, B., Ekız, F., Giniş, Z., Altınbaş, A., Aktaş, B., Tuna, Y., Çoban, Ş., Delibaş, N., & Yüksel, O. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.07.003 · Cited by 33
Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection
Pianko, S., Patella, S., & Sievert, W. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02083.x · Cited by 32
Saile, B., Eisenbach, C., Dudás, J., El-Armouche, H., & Ramadori, G. P. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00409 · Cited by 30
Post‐treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice
Wu, Y., Fang, H., & Lin, W. (2009) · Phytotherapy Research · doi:10.1002/ptr.2949 · Cited by 30
Karantonis, H. C., Gribilas, G., Stamoulis, I., Giaginis, C., Spiliopoulou, C., Kouraklis, G. P., Demopoulos, C. A., & Theocharis, S. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0745-0 · Cited by 28
Wang, Z.-X., Wang, Z., Ran, H., Ren, J., Zhang, Y., Li, Q., Zhu, Y., & Ao, M. (2009) · Clinical Imaging · doi:10.1016/j.clinimag.2009.07.001 · Cited by 27
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
de Oliveira, M. G., Mazo, D. F. D. C., Pereira, I. V. A., Cogliati, B., Stefano, J. T., Souza, Rabelo, F., Carrilho, de Oliveira, C. P. M. S., Lima, F. R., et al. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s43930 · Cited by 26
Yokomori, H., Oda, M., Yoshimura, K., & Hibi, T. (2011) · Micron · doi:10.1016/j.micron.2011.08.002 · Cited by 26
Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells
Ogawa, T., Kawada, N., & Ikeda, K. (2009) · Hepatology International · doi:10.1007/s12072-009-9129-y · Cited by 26
Klironomos, S., Notas, G., Sfakianaki, O., Kiagiadaki, F., Xidakis, C., & Kouroumalis, E. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.11.002 · Cited by 26
Daneshpour, N., Griffin, M., Collighan, R. J., & Perrie, Y. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.531731 · Cited by 25
Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fi brosis
Mas, N., Taşçı, İ., Cömert, B., Öçal, R., & Mas, M. R. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1108 · Cited by 25
Development of a New Animal Model of Liver Cirrhosis in Swine
Zhang, J.-J., Meng, X.-K., Dong, C., Qiao, J., Zhang, R.-F., Yue, G., & Zhong, H.-Y. (2008) · European Surgical Research · doi:10.1159/000167855 · Cited by 24
Varela‐Rey, M., Fontán, L., Blanco, P., López-Zabalza, M. J., & Iraburu, M. J. (2007) · Cytokine · doi:10.1016/j.cyto.2007.03.013 · Cited by 22
Hepatic Sinusoidal Endothelial Cell in Alcoholemia and Endotoxemia
Deaciuc, I. V., & Spitzer, J. J. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01662.x · Cited by 22
Establishment of an early liver fibrosis model by the hydrodynamics-based transfer of TGF-β1 gene
Yang, K.-L., Hung, K., Chang, W., & Li, E. I. C. (2007) · Comparative Hepatology · doi:10.1186/1476-5926-6-9 · Cited by 22
Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis
Vollmar, B., Siegmund, S., Richter, S., & Menger, M. D. (1999) · The Journal of Pathology · Cited by 21
Deaciuc, I. V. (2001) · Hepatology Research · doi:10.1016/s1386-6346(00)00087-5 · Cited by 20
Zhang, S.-H., Wen, K., Wu, W., Li, W., & Zhao, J. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.05.011 · Cited by 20
Inhibitory Effect of Antisense Oligonucleotide Targeting TIMP-2 on Immune-Induced Liver Fibrosis
Nie, Q., Zhu, C., Zhang, Y., Yang, J., Zhang, J.-C., & Gao, R. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0858-5 · Cited by 19
Su, X., Wang, Y., Zhou, G., Xu, Y., Yu, R., Lin, Y., & Zheng, C. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12182 · Cited by 18
Yao, X. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i17.2583 · Cited by 16
Lodge, J. K., & Packer, L. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-709-3_8 · Cited by 16
Inhibitory effect of human interferon‐beta‐1a on activated rat and human hepatic stellate cells
Rao, H., Wei, L., Wang, J., Fei, R., Jiang, D., Zhang, Q., Chen, H., & Xu, C. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06264.x · Cited by 15
Ji, G., Wang, L., Zhang, S.-H., Liu, J., Pei-yong, Z., & Liu, T. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i13.2047 · Cited by 14
Mouse Model of Primary Biliary Cirrhosis With Progressive Fibrosis: Are We There Yet?
Popov, Y. V. (2012) · Hepatology · doi:10.1002/hep.25969 · Cited by 14
Inagaki, Y., Higashiyama, R., & Okazaki, I. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00267.x · Cited by 11
Phyto-power dietary supplement potently inhibits dimethylnitrosamine-induced liver fibrosis in rats
Lee, M.-F., Tsai, M.-L., Sun, P.-P., Chien, L.-L., Cheng, A., Ma, N. J.-L., Ho, C., & Pan, M. (2012) · Food & Function · doi:10.1039/c2fo30306j · Cited by 8
Stolz, D. B. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_7 · Cited by 7
Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-β1
Doh, K., Jung, H.-K., Moon, I.-J., Kang, H.-G., Park, J., & Park, J.-G. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.1.33 · Cited by 7
Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cells
Li, Y. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1911 · Cited by 4
Cited by
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
“diff rentiation of Hepatic stellate cells (HSCs) into collagen-producing myofibroblasts [8,9].”
BackgroundInfluentialHypoxia signaling in human diseases and therapeutic targets
Lee, J. W., Ko, J., Ju, C., & Eltzschig, H. K. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0235-1 · Cited by 384
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
D'souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5759 · Cited by 257
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
Acharya, C., Sahingur, S. E., & Bajaj, J. S. (2017) · JCI Insight · doi:10.1172/jci.insight.94416 · Cited by 256
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine
De Andrade, K., Moura, F., Dos Santos, J., De Araújo, O., De Farias Santos, J., & Goulart, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226225 · Cited by 253
Metadata
- Authors
- Zhou, W.-C.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 23
- Pages
- 7312
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2068084277
- Cited by
- 627
- References
- 176
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.